Research - Washington, District of Columbia, United States
Located in the Greater Seattle Area, Celogics develops high-quality human induced pluripotent stem cell products to advance drug discovery, safety screening, and therapeutics research.Human iPSC-derived cells are rapidly becoming a vital tool in the drug development industry for the discovery, preclinical efficacy testing, and safety profiling of new medicines. Celogics is committed to developing and producing highly reproducible iPSCs that help cutting-edge researchers and pharmaceutical companies accelerate the discovery and development of next-generation therapies.
Gmail
Varnish
Wix
Mobile Friendly
Google Cloud Hosting